Results 181 to 190 of about 16,381,505 (407)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objectives Cognitive disorders are common in older persons with seizures (PWS). Cognitive disorders are often associated with impaired Instrumental Activities of Daily Living (IADLs). However, the effects of seizures on IADLs remain unexplored.
Ifrah Zawar +5 more
wiley +1 more source
External Evaluation and Cost-Benefit Analysis of mothers2mothers' Mentor Mother Programme in Uganda [PDF]
, 2015 This external evaluation examines whether the core component of m2m's Mentor Mother Model -- peer education an psychosocial support services -- improves the uptake of Prevention of Mother-To-Child Transmission (PMTCT) services, as wel as the health and ...
core
Genetic Diversity and Expanded Phenotypes in Dystonia: Insights From Large‐Scale Exome Sequencing
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Dystonia is one of the most prevalent movement disorders, characterized by significant clinical and etiological heterogeneity. Despite considerable heritability (~25%), the etiology in most patients remains elusive. Moreover, understanding correlations between clinical manifestations and genetic variants has become increasingly ...
Mirja Thomsen +47 more
wiley +1 more source
Update on Oral Health Services 2013 [PDF]
, 2012 https://digitalcommons.memphis.edu/govpubs-tn-dept-health-oral-health-services/1007/thumbnail ...
Tennessee. Department of Health.
core +4 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction The kappa‐free light chain (κ‐FLC) index is known to be highly sensitive and specific for diagnosing multiple sclerosis (MS), while little is understood about lambda (λ)‐FLC. This study assessed the κ‐FLC and λ‐FLC indices in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Michael Levraut +11 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo +11 more
wiley +1 more source